TP53 and breast carcinoma: The breast cancer study offers important clinical insights into chemotherapy response based on p53 status, highlighting the variability in chemotherapy efficacy based on tumor p53 status and the potential for customizing treatment strategies to optimize therapeutic outcomes in breast cancer and other malignancies [40].